Instead, topline typically comes first before publication. You seem to know something about how long this will take ("perhaps many months"), and yet you don’t know. You are guessing. Right now some people have pieced together the impression approximately 233OS data lock, external analysis followed by unblinding. That’s because that is what the company said publicly. Has that changed? Sounds like you think it changed.
You said:
And your SEC comments seem to be missing the timely issue: The SEC also believe in “timely and full disclosure” of things like “market applications, regulatory status of a clinical research program....” At least according to A. Ceresney. See article in PharmaExec.com
First, you started your statement with "if everything mentioned in those releases occurred as described...". The problem with NWBO is they give us a tidbit of info to collect $$$ from dilutive fundraises and then, after they get their $$$ (and dilute our shares) the go back to ignoring us. We seldom get details about the trial and, therefore, always have to resort to "If...". You indirectly imply that you don't even know if what they presented in the PR is true! No one does, hence the .27 pps.
So was the P3 OS threshold was reached...or not? There are no "deliberate process of review, analysis, review, analysis, and then more review and analysis until conclusions are drawn and papers are written and published" here. If NWBO met the P3 OS threshold, they should say it. If they have not (which would be even better since it would mean no one is dying), they should say it. It isn't complicated. Why should you, a johnny-come-lately (no offence, I welcome you) or a shareholder who is uncompromising in his/her support for 4 years now, not know this when NWBO set the expectation. This is inexcusable!
You believe the end game process involves a very careful, deliberate process of review, analysis, review, analysis, and then more review and analysis until conclusions are drawn and papers are written and published. I agree that the end game requires the company to methodically cross its Ts and dot its Is. But there should be periodic communications with shareholders. Where are the conference calls? When is the ASM?
IMHO, shareholders have given NWBO a blank check to do whatever the want with no accountability/transparency at all. I think the shareholders MUST send a clear message to NWBO:WE HAVE SUPPORTED YOU AND TRUSTED YOU. NOW WE INSIST THAT YOU PROVIDE BASIC, FUNDAMENTAL INFO REGARDING THE P3 TRIAL AND GOVERNANCE TO VALIDATE THAT TRUST AND EARN FURTHER TRUST!